The generic name of Actos is pioglitazone. It is a thiazolidinedione that is used to control type 2 diabetes. If you believe you were harmed by taking Actos, you may have a lawsuit against the developer and marketer of Actos, Takeda Pharmaceuticals U.S.A., Inc. As of the date of this update, December 5, 2017, we do not have any cases involving this medication.
The cases below are no longer active; however, if you think you have a case, please contact our attorneys using the form below.
Actos bladder cancer lawsuits throughout the United States have been consolidated in multidistrict litigation (MDL) in the United States District Court for the Western District of Louisiana. The defendant in these cases is Takeda Pharmaceuticals North America, Inc.
MDL is like a class action lawsuit, but only the pretrial proceedings are coordinated and consolidated. The Actos (Pioglitazone) Products Liability Litigation (MDL #2299) was assigned to the Honorable Rebecca F. Doherty.
All of the Actos lawsuits in MDL have one or more common questions of fact, but the cases were pending in different federal districts:
Each of these actions alleges claims arising from the use of Actos, a prescription medication approved for use in the treatment of type 2 diabetes. Plaintiffs allege that individuals who use Actos face an increased risk of developing bladder cancer. Plaintiffs further allege that the defendants concealed their knowledge of this risk and failed to provide adequate warnings to consumers and the health care community. Defendants deny all allegations of fault.
You can call 1-888-377-8900 (toll free) or click here now to get your free consultation.
For more information, please see the following:
